WHO ICTRP trial
Incidence and predictors of re-intervention after Novasure endometrial ablation…
NL-OMON20077 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON20077 |
|---|---|
| Public title | Incidence and predictors of re-intervention after Novasure endometrial ablation: a validation study in patients with abnormal uterine bleeding with data extraction from the Electronic Health Record and a Clinical Data Collector. |
| Scientific title | Effectivity of Novasure endometrial ablation for heavy menstrual bleeding: EHR vs CDC (novaSure Ehr vErsus cDc) |
| Primary sponsor | Máxima MC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Conditions | Abnormal Uterine Bleeding |
| Interventions | Novasure endometrial ablation |
| Registration date | Jan 19, 2021 |
| Target size | 120 |
| Secondary IDs | NL9268;Commissie Lokale Uitvoerbaarheid Máxima Medical Center : L20.188 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: